Expression of an alternatively spliced variant of SORL1 in neuronal dendrites is decreased in patients with Alzheimer's disease

阿尔茨海默病患者神经元树突中SORL1的另一种剪接变体的表达降低

阅读:4
作者:Giulia Monti ,Mads Kjolby ,Anne Mette G Jensen ,Mariet Allen ,Juliane Reiche ,Peter L Møller ,Raquel Comaposada-Baró ,Bartlomiej E Zolkowski ,Cármen Vieira ,Margarita Melnikova Jørgensen ,Ida E Holm ,Paul N Valdmanis ,Niels Wellner ,Christian B Vægter ,Sarah J Lincoln ,Anders Nykjær ,Nilüfer Ertekin-Taner ,Jessica E Young ,Mette Nyegaard ,Olav M Andersen

Abstract

SORL1 is strongly associated with both sporadic and familial forms of Alzheimer's disease (AD), but a lack of information about alternatively spliced transcripts currently limits our understanding of the role of SORL1 in AD. Here, we describe a SORL1 transcript (SORL1-38b) characterized by inclusion of a novel exon (E38b) that encodes a truncated protein. We identified E38b-containing transcripts in several brain regions, with the highest expression in the cerebellum and showed that SORL1-38b is largely located in neuronal dendrites, which is in contrast to the somatic distribution of transcripts encoding the full-length SORLA protein (SORL1-fl). SORL1-38b transcript levels were significantly reduced in AD cerebellum in three independent cohorts of postmortem brains, whereas no changes were observed for SORL1-fl. A trend of lower 38b transcript level in cerebellum was found for individuals carrying the risk variant at rs2282649 (known as SNP24), although not reaching statistical significance. These findings suggest synaptic functions for SORL1-38b in the brain, uncovering novel aspects of SORL1 that can be further explored in AD research. Keywords: Alternative splicing; Alzheimer’s disease; Dendritic transcript; SORL1; SORLA.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。